Ketone Metabolite β-Hydroxybutyrate Ameliorates Inflammation After Spinal Cord Injury by Inhibiting the NLRP3 Inflammasome

作者：Kong, Ganggang; Liu, Junhao; Li, Rong; Lin, Junyu; Huang, Zucheng; Yang, Zhou; Wu, Xiuhua; Huang, Zhiping; Zhu, Qingan^*; Wu, Xiaoliang^*

来源：Neurochemical Research, 2021, 46(2): 213-229.

DOI：10.1007/s11064-020-03156-2

• &#946
• -Hydroxybutyrate
• Ketogenic diet
• Macrophages
• microglia
• NLRP3 inflammasome
• Spinal cord injury

Ketogenic diet (KD) has been shown to be beneficial in a range of neurological disorders, with ketone metabolite beta-hydroxybutyrate (beta OHB) reported to block the nucleotide oligomerization domain-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome in bone marrow-derived macrophages. In this study, we show that pretreatment with KD or in situ beta OHB suppressed macrophages/microglia activation and the overproduction of inflammatory cytokines, while KD downregulated the expression of NLRP3 inflammasome. Moreover, KD promoted macrophages/microglia transformation from the M1 phenotype to the M2a phenotype following spinal cord injury (SCI) in the in vivo study. Rats in the KD group demonstrated improved behavioral and electrophysiological recovery after SCI when compared to those rats in the standard diet group. The in vitro study performed on BV2 cells indicated that beta OHB inhibited an LPS+ATP-induced inflammatory response and decreased NLRP3 protein levels. Our data demonstrated that pretreatment with KD attenuated neuroinflammation following SCI, probably by inhibiting NLRP3 inflammasome and shifting the activation state of macrophages/microglia from the M1 to the M2a phenotype. Therefore, the ketone metabolite beta OHB might provide a potential future therapeutic strategy for SCI.

• 单位
  1; 中山大学; 南方医科大学